Biogen checks 'yes' with $30M opt-in on Roche's lymphoma bispecific as regulatory filings ...

Retrieved on: 2022-02-01 16:10:50

Tags for this article:

Click the tags to see associated articles and topics

Biogen checks 'yes' with $30M opt-in on Roche's lymphoma bispecific as regulatory filings .... View article details on hiswai:

Excerpt

Biogen and Roche's Genentech are looking to follow up on their multidecade history of getting medicines approved together, with the Aduhelm maker ...

Article found on: www.fiercebiotech.com